세계의 혈장 유도체 시장 규모 조사 및 예측 : 유형별, 용도별, 최종 사용자별, 지역별 분석(2023-2030년)

Global Blood Plasma Derivatives Market is valued at approximately USD 43650.9 million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2023-2030. The blood plasma derivatives market refers to the segment of the pharmaceutical industry that involves the collection, processing, and commercialization of therapeutic products derived from human blood plasma. These derivatives are obtained through a complex manufacturing process that includes fractionation, purification, and sterilization to isolate and extract specific proteins, antibodies, and other bioactive substances found in blood plasma. These products are used for various therapeutic purposes, including treating immune disorders, coagulation disorders, and certain genetic diseases. The blood plasma derivatives market is being driven by factors such as the increasing geriatric population that are more susceptible to developing infectious diseases and the Increasing prevalence of chronic diseases.

Blood plasma derivatives play a crucial role in the treatment of various medical conditions and provide therapeutic options for patients with immune deficiencies, coagulation disorders, and other diseases. According to the International Diabetes Federation (IDF), diabetes can afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050.Thus, the growing prevalence of chronic disease and the growing aging population fueling the growth of the market. In addition, increasing awareness & diagnosis of rare diseases and technological advancements in plasma fractionation. However, strict regulatory compliances may hinder the growth of the market throughout the forecast period of 2023-2030.

The key regions considered for the Global Blood Plasma Derivatives Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-developed healthcare infrastructure, including hospitals, clinics, and diagnostic centers. These facilities have advanced capabilities for blood plasma collection, processing, and manufacturing of derivatives, leading to a robust market for plasma-based products. North America is also considered the fastest growing region during the forecasted period due to the high demand for plasma-derived products and reimbursement systems.

Major market player included in this report are:

• Baxter International Inc.
• Bayer AG
• CSL Limited
• Fusion Health Care Pvt. Ltd.
• Grifols S.A.
• Kedrion S.p.A.
• LFB S.A.
• Octapharma AG
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited

Recent Developments in the Market:

• In March 2020, Grifols collaborates with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease. Grifols will volunteer its expertise and resources in the areas of plasma collection using its network of FDA-approved plasma donor centers; test and qualify donors in conjunction with other health agencies; process plasma into hyperimmune globulin in its purpose-built facility in Clayton, North Carolina, for the isolated processing of immune globulins to treat emerging infectious diseases.

Global Blood Plasma Derivatives Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: , Type, Application, End User, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Albumin
• Factor VIII
• Factor IX
• Immunoglobulin
• Hyperimmune Globulin
• Others

By Application:

• Hemophilia
• Hypogammaglobulinemia
• Immunodeficiency Diseases
• Von Willebrand'S Disease
• Other Application

By End User:

• Hospitals
• Clinics
• Others End User

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Blood Plasma Derivatives Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Blood Plasma Derivatives Market, by Type, 2020-2030 (USD Million)
  • 1.2.3. Blood Plasma Derivatives Market, by Application, 2020-2030 (USD Million)
  • 1.2.4. Blood Plasma Derivatives Market, by End User, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Blood Plasma Derivatives Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Blood Plasma Derivatives Market Dynamics

• 3.1. Blood Plasma DerivativesMarket Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of chronic diseases
    • 3.1.1.2. Growing Geriatric Population
  • 3.1.2. Market Challenges
    • 3.1.2.1. Strict regulatory compliances
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing awareness & diagnosis of rare diseases
    • 3.1.3.2. Technological advancements in plasma fractionation

Chapter 4. Global Blood Plasma DerivativesMarket Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Blood Plasma DerivativesMarket, by Type

• 5.1. Market Snapshot
• 5.2. Global Blood Plasma DerivativesMarket by Type, Performance - Potential Analysis
• 5.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Type 2020-2030 (USD Million)
• 5.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
  • 5.4.1. Albumin
  • 5.4.2. Factor VIII
  • 5.4.3. Factor IX
  • 5.4.4. Immunoglobulin
  • 5.4.5. Hyperimmune Globulin
  • 5.4.6. Others

Chapter 6. Global Blood Plasma DerivativesMarket, by Application

• 6.1. Market Snapshot
• 6.2. Global Blood Plasma DerivativesMarket by Application, Performance - Potential Analysis
• 6.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Application 2020-2030 (USD Million)
• 6.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
  • 6.4.1. Hemophilia
  • 6.4.2. Hypogammaglobulinemia
  • 6.4.3. Immunodeficiency Diseases
  • 6.4.4. Von Willebrand'S Disease
  • 6.4.5. Other Application

Chapter 7. Global Blood Plasma DerivativesMarket, by End User

• 7.1. Market Snapshot
• 7.2. Global Blood Plasma DerivativesMarket by End User, Performance - Potential Analysis
• 7.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by End User 2020-2030 (USD Million)
• 7.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Clinics
  • 7.4.3. Others End User

Chapter 8. Global Blood Plasma DerivativesMarket, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Blood Plasma DerivativesMarket, Regional Market Snapshot
• 8.4. North America Blood Plasma DerivativesMarket
  • 8.4.1. U.S. Blood Plasma DerivativesMarket
    • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Blood Plasma DerivativesMarket
• 8.5. Europe Blood Plasma DerivativesMarket Snapshot
  • 8.5.1. U.K. Blood Plasma DerivativesMarket
  • 8.5.2. Germany Blood Plasma DerivativesMarket
  • 8.5.3. France Blood Plasma DerivativesMarket
  • 8.5.4. Spain Blood Plasma DerivativesMarket
  • 8.5.5. Italy Blood Plasma DerivativesMarket
  • 8.5.6. Rest of Europe Blood Plasma DerivativesMarket
• 8.6. Asia-Pacific Blood Plasma DerivativesMarket Snapshot
  • 8.6.1. China Blood Plasma DerivativesMarket
  • 8.6.2. India Blood Plasma DerivativesMarket
  • 8.6.3. Japan Blood Plasma DerivativesMarket
  • 8.6.4. Australia Blood Plasma DerivativesMarket
  • 8.6.5. South Korea Blood Plasma DerivativesMarket
  • 8.6.6. Rest of Asia Pacific Blood Plasma DerivativesMarket
• 8.7. Latin America Blood Plasma DerivativesMarket Snapshot
  • 8.7.1. Brazil Blood Plasma DerivativesMarket
  • 8.7.2. Mexico Blood Plasma DerivativesMarket
• 8.8. Middle East & Africa Blood Plasma DerivativesMarket
  • 8.8.1. Saudi Arabia Blood Plasma DerivativesMarket
  • 8.8.2. South Africa Blood Plasma DerivativesMarket
  • 8.8.3. Rest of Middle East & Africa Blood Plasma DerivativesMarket

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Baxter International Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Bayer AG
  • 9.3.3. CSL Limited
  • 9.3.4. Fusion Health Care Pvt. Ltd.
  • 9.3.5. Grifols S.A.
  • 9.3.6. Kedrion S.p.A.
  • 9.3.7. LFB S.A.
  • 9.3.8. Octapharma AG
  • 9.3.9. Sanofi S.A.
  • 9.3.10. Takeda Pharmaceutical Company Limited

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption